Patient Guide: OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 26 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06355934
Status: 🟢 Enrolling Now
Condition: ATTR Amyloidosis
Phase: Not Specified

Where You Can Participate

This study is available at 26 locations across the country.

Top locations include:
  • • Eden Prairie, Minnesota
  • • Calgary, Alberta
  • • Beijing,
  • • And 23 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis - Join Clinical Trial NCTNCT06355934

How to Join This Clinical Trial - NCTNCT06355934

Learn how to participate in this Not Specified trial studying an investigational therapy for ATTR Amyloidosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with ATTR Amyloidosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
ATTR Amyloidosis
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06355934 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 26 locations. Find a study site near you:

Clinical Research Site

Eden Prairie, Minnesota 55344 - United States

Status: COMPLETED

Clinical Research Site

Calgary, Alberta T2P 4K7 - Canada

Status: RECRUITING

Clinical Research Site

Beijing, - China

Status: COMPLETED

Clinical Research Site

Changsha, - China

Status: COMPLETED

Clinical Research Site

Chengdu, - China

Status: COMPLETED

Clinical Research Site

Guangzhou, - China

Status: COMPLETED

Clinical Research Site

Wuhan, - China

Status: COMPLETED

Clinical Research Site

Horsens, - Denmark

Status: RECRUITING

Clinical Research Site

Berlin, - Germany

Status: RECRUITING

Clinical Research Site

Tokyo, - Japan

Status: COMPLETED

And 16 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for ATTR Amyloidosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships